[Follow-up of patients after an acute coronary event: the Apulia PONTE-SCA program].

医学 内科学 急性冠脉综合征 心脏病学 不稳定型心绞痛 血运重建 再狭窄 狼牙棒 支架 阿司匹林 心肌梗塞 经皮冠状动脉介入治疗
作者
Nicola Locuratolo,Pietro Scicchitano,Ettore Antoncecchi,P Basso,V. M. Bonfantino,F. Brescia,Francesco Carrata,Giulia Martino,Raffaella Landriscina,Saverio Lanzone,A. Di Lillo,Francesco Massari,Sergio Musci,Vincenzo Davide Palumbo,Claudio Paolillo,David Rutigliano,Sergio Rutigliano,Lucia Sublimi Saponetti,Giuseppe Scalera,Teresa Spadafina,Elisabetta Squiccimarro,Francesco Tota,Pasquale Caldarola
出处
期刊:PubMed 卷期号:23 (1): 63-74 被引量:3
标识
DOI:10.1714/3715.37064
摘要

Patients who suffered from acute coronary syndrome (ACS) need a tight follow-up in order to optimize therapy and prevent adverse events. The aim of the PONTE-SCA Puglia program was to evaluate the impact of an integrated management of patients between hospital and local territorial outpatient facilities on adherence and outcome of patients discharged after ACS event.This was a prospective, longitudinal, cohort study which enrolled patients who suffered ACS and/or coronary revascularization in a Hub hospital of ASL Bari. Patients underwent clinical and laboratory evaluation at 30 days, 3 months, 6 months, and 1 year after the index event. The following endpoints were considered: all-cause mortality, ACS recurrence/cardiac ischemia/angina, restenosis/intrastent thrombosis, stroke/transient ischemic attack, heart failure, all-cause bleeding. We evaluated persistence on therapies and the percentage of patients who attained therapeutic goals.A total of 2476 patients (mean age 67.2 ± 12.0 years, 77.4% male) were enrolled. At 1-year follow-up, 99.5% of patients (p<0.05) were on statin therapy, 16.1% (p<0.01) on ezetimibe, and 9.9% (p<0.01) on proprotein convertase subtilisin/kexin type 9 inhibitors. All-cause mortality was 3.1% at 1-year follow-up, whereas recurrence of ACS/cardiac ischemia/angina and restenosis/stent thrombosis were 3% and 1.3%, respectively. The prevalence of all bleeding complications was 2.2%.The PONTE-SCA Puglia program allowed to implement a dedicated taking in charge of patients after an ACS/coronary revascularization event, to manage a dedicated follow-up route for them, to ameliorate persistence on recommended therapies, and to keep lower the incidence of major adverse cardiovascular events and bleedings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
学术渣渣发布了新的文献求助10
刚刚
刚刚
dadayou完成签到,获得积分10
刚刚
orixero应助安详的映寒采纳,获得10
1秒前
1秒前
大卫戴完成签到 ,获得积分10
1秒前
整齐的萝完成签到,获得积分20
3秒前
zhao完成签到 ,获得积分10
4秒前
NeXt_best发布了新的文献求助10
5秒前
Luna完成签到 ,获得积分10
5秒前
6秒前
水平做发布了新的文献求助10
6秒前
zafan发布了新的文献求助10
6秒前
infinite完成签到,获得积分10
6秒前
疯了发布了新的文献求助10
7秒前
Akim应助舒适的藏花采纳,获得10
8秒前
陈强完成签到,获得积分10
8秒前
英俊的铭应助甜甜的雨灵采纳,获得10
9秒前
vvvvvv应助科研通管家采纳,获得10
9秒前
科研通AI2S应助科研通管家采纳,获得10
9秒前
丘比特应助科研通管家采纳,获得10
9秒前
彭于彦祖应助科研通管家采纳,获得10
9秒前
hjyylab应助科研通管家采纳,获得10
9秒前
思源应助科研通管家采纳,获得10
9秒前
Lucas应助科研通管家采纳,获得30
9秒前
小二郎应助科研通管家采纳,获得10
9秒前
Hello应助科研通管家采纳,获得10
10秒前
李爱国应助科研通管家采纳,获得10
10秒前
10秒前
bkagyin应助科研通管家采纳,获得10
10秒前
赘婿应助科研通管家采纳,获得30
10秒前
科研通AI5应助科研通管家采纳,获得10
10秒前
小二郎应助科研通管家采纳,获得10
10秒前
情怀应助科研通管家采纳,获得10
10秒前
ding应助科研通管家采纳,获得10
10秒前
bkagyin应助科研通管家采纳,获得10
10秒前
科研通AI5应助科研通管家采纳,获得10
10秒前
搜集达人应助科研通管家采纳,获得10
10秒前
某某完成签到 ,获得积分10
10秒前
wanci应助科研通管家采纳,获得10
10秒前
高分求助中
Applied Survey Data Analysis (第三版, 2025) 800
Narcissistic Personality Disorder 700
Assessing and Diagnosing Young Children with Neurodevelopmental Disorders (2nd Edition) 700
Handbook of Experimental Social Psychology 500
The Martian climate revisited: atmosphere and environment of a desert planet 500
Transnational East Asian Studies 400
Towards a spatial history of contemporary art in China 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3845729
求助须知:如何正确求助?哪些是违规求助? 3388049
关于积分的说明 10551625
捐赠科研通 3108709
什么是DOI,文献DOI怎么找? 1713014
邀请新用户注册赠送积分活动 824576
科研通“疑难数据库(出版商)”最低求助积分说明 774891